Newsletter

Fibrodysplasia Ossificans Progressiva
With no cure at hand Pharma companies gear up to offer relief to patients suffering from a sporadic connective tissue disease.
Fibrodysplasia Ossificans Progressiva Newsletter

More Whitepapers / Newsletters

Emergence of E-Pharmacies Whitepaper
Emergence of E-Pharmacies: Cha...

In the past few years, online buying has become the easiest way to purchase products and services. The ever increasing users of the internet services have led to the blooming of the e-commerce sector...

Induced Pluripotent Stem Cells (IPSCs) Research And Development
Induced Pluripotent Stem Cells...

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are u...

Retinitis Pigmentosa
Retinitis Pigmentosa

Retinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye is inflicted upon the light-sensitive tissue – the retina, which is the leading cause of blindness....

Lean Management
Lean Management: Following the...

Lean is a multi-faceted framework that allows organisations to exercise different initiatives simultaneously in many dimensions; some consider effective execution either by achieving major strategic c...

Microneedles Whitepaper
Microneedles: A Smart and Pain...

A formal medical disorder affecting approximately 10 percent of the world population is trypanophobia, or the fear of needles. Nonetheless, transcutaneous or transdermal injections and intravenous inj...